Ignite Creation Date:
2025-12-24 @ 10:00 PM
Ignite Modification Date:
2026-03-11 @ 3:41 AM
Study NCT ID:
NCT00090532
Status:
TERMINATED
Last Update Posted:
2011-05-27
First Post:
2004-08-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D008268', 'term': 'Macular Degeneration'}], 'ancestors': [{'id': 'D012162', 'term': 'Retinal Degeneration'}, {'id': 'D012164', 'term': 'Retinal Diseases'}, {'id': 'D005128', 'term': 'Eye Diseases'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE1', 'PHASE2'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'DOUBLE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'count': 155}}, 'statusModule': {'whyStopped': 'This study was terminated due to a lack of efficacy.', 'overallStatus': 'TERMINATED', 'startDateStruct': {'date': '2004-01'}, 'statusVerifiedDate': '2011-05', 'completionDateStruct': {'date': '2006-08', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2011-05-26', 'studyFirstSubmitDate': '2004-08-26', 'studyFirstSubmitQcDate': '2004-08-30', 'lastUpdatePostDateStruct': {'date': '2011-05-27', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2004-08-31', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'To evaluate the ocular and systemic safety of the study drug'}], 'secondaryOutcomes': [{'measure': 'To evaluate the visual acuity change after study treatment'}]}, 'conditionsModule': {'conditions': ['Age-Related Macular Degeneration']}, 'referencesModule': {'seeAlsoLinks': [{'url': 'https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A4321001&StudyName=A+Study+Of+The+Safety+And+Efficacy+Of+AG%2D013%2C958+In+Subjects+With+Subfoveal+Choroidal+Neovascularization+Associated+With+Age%2DRelated+Macular+Degeneration++', 'label': 'To obtain contact information for a study center near you, click here.'}]}, 'descriptionModule': {'briefSummary': 'AG-013,958 is being studied to treat patients with Age-Related Macular Degeneration. A total of 144 subjects may be enrolled in the trial. Subjects will be male or female at least 55 years of age with "wet" age-related macular degeneration.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '55 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Male and/or female subjects \\>=55 years of age\n* Subfoveal choroidal neovascularization complicating age-related macular degeneration\n* Subjects who are informed of, and willing and able to comply with, the investigational nature of the study and are able to provide written informed consent in accordance with institutional and regulatory guidelines\n\nExclusion Criteria:\n\n* Other serious ocular diseases or conditions, including diabetic retinopathy and glaucoma, that are likely to compromise visual acuity within 1 year'}, 'identificationModule': {'nctId': 'NCT00090532', 'briefTitle': 'A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration', 'organization': {'class': 'INDUSTRY', 'fullName': 'Pfizer'}, 'officialTitle': 'A Phase 1/2, Randomized, Masked, Single and Multiple-Dose, Sequential Dose-Escalation Study of the Safety an Efficacy of AG-013958 in Subjects With Subfoveal Choroidal Neovascularization Associated With Age-related Macular Degeneration', 'orgStudyIdInfo': {'id': 'A4321001'}}, 'armsInterventionsModule': {'interventions': [{'name': 'AG-013,958', 'type': 'DRUG'}]}, 'contactsLocationsModule': {'locations': [{'city': 'Mesa', 'state': 'Arizona', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 33.42227, 'lon': -111.82264}}, {'city': 'Oro Valley', 'state': 'Arizona', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 32.39091, 'lon': -110.96649}}, {'city': 'Phoenix', 'state': 'Arizona', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 33.44838, 'lon': -112.07404}}, {'city': 'Sun City', 'state': 'Arizona', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 33.59754, 'lon': -112.27182}}, {'city': 'Tucson', 'state': 'Arizona', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 32.22174, 'lon': -110.92648}}, {'city': 'Tuscon', 'state': 'Arizona', 'country': 'United States', 'facility': 'Pfizer Investigational Site'}, {'city': 'Beverly Hills', 'state': 'California', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 34.07362, 'lon': -118.40036}}, {'city': 'Fort Myers', 'state': 'Florida', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 26.62168, 'lon': -81.84059}}, {'city': 'Tampa', 'state': 'Florida', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 27.94752, 'lon': -82.45843}}, {'city': 'Iowa City', 'state': 'Iowa', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 41.66113, 'lon': -91.53017}}, {'city': 'Chevy Chase', 'state': 'Maryland', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 39.00287, 'lon': -77.07115}}, {'city': 'Hagerstown', 'state': 'Maryland', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 39.64176, 'lon': -77.71999}}, {'city': 'Boston', 'state': 'Massachusetts', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 42.35843, 'lon': -71.05977}}, {'city': 'Ann Arbor', 'state': 'Michigan', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 42.27756, 'lon': -83.74088}}, {'city': 'Livonia', 'state': 'Michigan', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 42.36837, 'lon': -83.35271}}, {'city': 'Rochester', 'state': 'Michigan', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 42.68059, 'lon': -83.13382}}, {'city': 'Royal Oak', 'state': 'Michigan', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 42.48948, 'lon': -83.14465}}, {'city': 'Saint Clair Shores', 'state': 'Michigan', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 42.49698, 'lon': -82.88881}}, {'city': 'Ypsilanti', 'state': 'Michigan', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 42.24115, 'lon': -83.61299}}, {'city': 'Slingerlands', 'state': 'New York', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 42.62925, 'lon': -73.86457}}, {'city': 'Charlotte', 'state': 'North Carolina', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 35.22709, 'lon': -80.84313}}, {'city': 'Huntersville', 'state': 'North Carolina', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 35.41069, 'lon': -80.84285}}, {'city': 'Cleveland', 'state': 'Ohio', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 41.4995, 'lon': -81.69541}}, {'city': 'Lakewood', 'state': 'Ohio', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 41.48199, 'lon': -81.79819}}, {'city': 'Portland', 'state': 'Oregon', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 45.52345, 'lon': -122.67621}}, {'city': 'Chambersburg', 'state': 'Pennsylvania', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 39.93759, 'lon': -77.6611}}, {'city': 'Columbia', 'state': 'South Carolina', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 34.00071, 'lon': -81.03481}}, {'city': 'Knoxville', 'state': 'Tennessee', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 35.96064, 'lon': -83.92074}}, {'city': 'Houston', 'state': 'Texas', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 29.76328, 'lon': -95.36327}}, {'city': 'Fairfax', 'state': 'Virginia', 'country': 'United States', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 38.84622, 'lon': -77.30637}}, {'city': 'Sydney', 'state': 'New South Wales', 'country': 'Australia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': -33.86785, 'lon': 151.20732}}, {'city': 'East Melbourne', 'state': 'Victoria', 'country': 'Australia', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': -37.81667, 'lon': 144.9879}}, {'city': 'Nijmegen', 'state': 'Gelderland', 'country': 'Netherlands', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 51.8425, 'lon': 5.85278}}, {'city': 'Amsterdam', 'state': 'North Holland', 'country': 'Netherlands', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 52.37403, 'lon': 4.88969}}, {'city': 'Groningen', 'state': 'Provincie Groningen', 'country': 'Netherlands', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 53.21917, 'lon': 6.56667}}, {'city': 'Rotterdam', 'state': 'South Holland', 'country': 'Netherlands', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 51.9225, 'lon': 4.47917}}, {'city': 'Aberdeen', 'state': 'Scotland', 'country': 'United Kingdom', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 57.14369, 'lon': -2.09814}}, {'city': 'Bristol', 'country': 'United Kingdom', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 51.45523, 'lon': -2.59665}}, {'city': 'London', 'country': 'United Kingdom', 'facility': 'Pfizer Investigational Site', 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}], 'overallOfficials': [{'name': 'Pfizer CT.gov Call Center', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Pfizer'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Pfizer', 'class': 'INDUSTRY'}}}}